Methods and compositions for treating inflammation
AssigneeUTI Limited Partnership
InventorPedro SANTAMARIA
Life of this patent
Estimating the term…
Abstract
This disclosure provides therapeutic compositions and methods for inducing an anti-inflammatory response and/or treating inflammation in the gastrointestinal tract and/or accumulating gut microbial antigen-specific anti-inflammatory T cells in a patient in need thereof.
Claims15
-30. (canceled)
A method for treating inflammation in the gastrointestinal (GI) tract of a patient in need thereof comprising parenterally administering to the patient an effective amount of a nanoparticle composition, wherein the composition does not comprise an adjuvant, wherein the composition comprises a plurality of nanoparticle cores, each nanoparticle core coupled to a plurality of peptide antigen-MHC complexes, wherein:
- the peptide antigen comprises an epitope of the peptide having at least 80% identity to the peptide sequence of SEQ ID No. 2;
- the nanoparticle core has a diameter from about 1 nm to about 100 nm;
- and
- the ratio of peptide antigen-MHC complexes per nanoparticle core is from about 10:1 to about 1000:1;
- and
- the peptide antigen is a T cell epitope.
Dependencies are inferred from the claim text.